Mechanism of Action: Cystine Disulfide Reduction
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cystine Disulfide Reduction
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa Inc | TIOPRONIN | tiopronin | TABLET;ORAL | 214326-001 | Apr 26, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Torrent | TIOPRONIN | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216990-001 | Jan 30, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Torrent | TIOPRONIN | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216990-002 | Jan 30, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amneal | TIOPRONIN | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216278-001 | Aug 15, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |